Company Filing History:
3 out of 9 
2 out of 9,157 
1 out of 1 Years Active: 1999-2020
Title: Shyh-Shyan Lin: Innovator in Mucosal and Inflammatory Disease Treatments
Introduction
Shyh-Shyan Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatments, particularly focusing on mucosal and inflammation-related disorders. With a total of 5 patents, Lin's work has the potential to improve the quality of life for many patients suffering from various conditions.
Latest Patents
Lin's latest patents include innovative compositions aimed at treating and preventing mucosa-related diseases. One notable invention is a hyaluronic acid (HA) composition designed for use in treating or preventing mucosal disorders. This formulation combines HAs with different average molecular weights and properties, achieving an optimal balance for treating conditions such as conjunctivitis, otitis, allergic rhinitis, and more. Another significant patent involves a composition for treating inflammation-related disorders, which utilizes HA as a delivery vehicle. This invention has shown promise in reducing the therapeutic dose of drugs for conditions like chronic obstructive pulmonary disease, rheumatoid arthritis, and various gastrointestinal disorders.
Career Highlights
Throughout his career, Shyh-Shyan Lin has worked with notable organizations, including Aihol Corporation and the Industrial Technology Research Institute. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Lin has collaborated with esteemed colleagues such as Jyh-Chyang Yang and Tsung Chung Wu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Shyh-Shyan Lin's contributions to the field of medical innovation are noteworthy. His patents reflect a commitment to improving treatment options for mucosal and inflammatory diseases. Through his work, Lin continues to pave the way for advancements in healthcare.